Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 9289 - 9296 of 11616 results
ML Strategies Posts Weekly Health Care Update on February 23, 2015
February 26, 2015| Blog| Viewpoint
The Court's Decision in the FLANAX US Trademark Dispute Gives Bayer a Headache
February 25, 2015| Blog| Viewpoint
The City of Philadelphia Enacts Paid Sick Leave Law
February 25, 2015| Blog| Viewpoint
Bayer Given a Headache by Trial Court Decision in FLANAX US Trademark Dispute
February 25, 2015| Blog| Viewpoint
ML Strategies: Keystone XL, Energy Efficiency Heat Up in Congress
February 25, 2015| Blog| Viewpoint
The YouTube Kids app is here! Now what?
February 25, 2015| Blog| Viewpoint
Telehealth Bill Moving Forward in Florida-But Medicaid Coverage Sacrificed
February 25, 2015| Blog| Viewpoint
News & Press Releases
Mintz Announces New Members
December 20, 2024
Mintz announces the election of eight attorneys to Members, effective January 1, 2025. The newly promoted Members join the ranks of the firm’s growing membership, including six new lateral Members who joined the firm in 2024.
Mintz represented the US Department of Energy (DoE) Loan Programs Office (LPO) in the closing of a $1.45 billion loan guarantee to Hanwha Q Cells Georgia, Inc. (QCells), a leading North American crystalline silicon solar manufacturer.
Dealmaking Dormant No More
December 17, 2024
International Chair of Life Sciences Cheryl Reicin recently participated in a Q&A with Pharmaceutical Executive in which she discusses the ongoing effects of the pandemic on dealmaking trends in the pharmaceutical industry. Cheryl specifically mentions how M&A activity began to rise again in 2024 after slowing in 2023, and that she expects acquisitions to continue picking up in 2025.